ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 331 filers reported holding ROYALTY PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144 | -80.2% | 5,300 | -77.6% | 0.00% | -60.0% |
| Q2 2023 | $727 | +71.9% | 23,644 | +101.5% | 0.01% | 0.0% |
| Q1 2023 | $423 | -99.9% | 11,734 | -28.6% | 0.01% | -37.5% |
| Q3 2022 | $660,000 | -19.7% | 16,437 | -15.9% | 0.01% | -11.1% |
| Q2 2022 | $822,000 | +16.6% | 19,551 | +8.0% | 0.01% | +80.0% |
| Q1 2022 | $705,000 | -24.9% | 18,096 | -30.4% | 0.01% | +25.0% |
| Q3 2021 | $939,000 | +99.8% | 25,983 | +126.5% | 0.00% | +100.0% |
| Q2 2021 | $470,000 | -68.7% | 11,474 | -66.6% | 0.00% | -75.0% |
| Q1 2021 | $1,500,000 | +129.0% | 34,399 | +162.7% | 0.01% | +166.7% |
| Q4 2020 | $655,000 | – | 13,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |